References

Obsessive–compulsive disorder

10.1038/s41572-019-0102-3 · 2019 · External reference

Unresolved reference

2022 · External reference

A systematic review of evidence-based treatment strategies for obsessive- compulsive disorder resistant to first-line pharmacotherapy

10.2174/0929867325666171222163645 · 2018 · External reference

Evidence-based pharmacotherapy of obsessive-compulsive disorder

10.1017/s1461145711001829 · 2012 · External reference

Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients

10.3389/fpsyt.2023.1065812 · 2023 · External reference

Treatment-resistant OCD: pharmacotherapies in adults

10.1016/j.comppsych.2022.152352 · 2023 · External reference

Clinical practice guidelines for obsessive-compulsive disorder: 2025 update

10.4103/indianjpsychiatry_1259_25 · 2026 · External reference

Identifying biological markers for improved precision medicine in psychiatry

10.1038/s41380-019-0555-5 · 2020 · External reference

Microbiome definition re-visited: old concepts and new challenges

10.1186/s40168-020-00875-0 · 2020 · External reference

Microbiota in health and diseases

10.1038/s41392-022-00974-4 · 2022 · External reference

Microbiota-brain axis: Exploring the role of gut microbiota in psychiatric disorders - A comprehensive review

10.1016/j.ajp.2024.104068 · 2024 · External reference

IUPHAR review: Microbiota-gut-brain axis and its role in neuropsychiatric disorders

10.1016/j.phrs.2025.107749 · 2025 · External reference

The critical role of gut-brain axis microbiome in mental disorders

10.1007/s11011-023-01248-w · 2023 · External reference

Microbiota-gut brain axis involvement in neuropsychiatric disorders

10.1080/14737175.2019.1638763 · 2019 · External reference

Linking the gut microbiota to a brain neurotransmitter

10.1016/j.tins.2018.04.001 · 2018 · External reference

An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders

10.1016/j.pnpbp.2023.110861 · 2024 · External reference

Identification of human gut bacteria that produce bioactive serotonin and promote colonic innervation

10.1016/j.celrep.2025.116434 · 2025 · External reference

Gut microbiota is a potential biomarker in inflammatory bowel disease

10.3389/fnut.2021.818902 · 2022 · External reference

The human gut microbiome – a potential controller of wellness and disease

10.3389/fmicb.2018.01835 · 2018 · External reference

Gut microbiome-host interactions in health and disease

10.1186/gm228 · 2011 · External reference

Modulating the microbiome to improve therapeutic response in cancer

10.1016/s1470-2045(18)30952-5 · 2019 · External reference

Applications of machine learning in human microbiome studies: A review on feature selection, biomarker identification, disease prediction and treatment

10.3389/fmicb.2021.634511 · 2021 · External reference

Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target

10.1186/s40164-023-00442-x · 2023 · External reference

Characterization of gut microbiome in mice model of depression with divergent response to escitalopram treatment

10.1038/s41398-021-01428-1 · 2021 · External reference

The role of gut microbiota and metabolomic pathways in modulating the efficacy of SSRIs for major depressive disorder

10.1038/s41398-024-03208-z · 2024 · External reference

Gut microbiota and obsessive–compulsive disorder: A systematic review of mechanistic links, evidence from human and preclinical studies, and therapeutic prospects

10.3390/life15101585 · 2025 · External reference

The gut microbiome and inflammation in obsessive-compulsive disorder patients compared to age- and sex-matched controls: a pilot study

10.1111/acps.13175 · 2020 · External reference

Changes in the stool and oropharyngeal microbiome in obsessive-compulsive disorder

10.1038/s41598-022-05480-9 · 2022 · External reference

Human microbiota from drug-naive patients with obsessive-compulsive disorder drives behavioral symptoms and neuroinflammation via succinic acid in mice

10.1038/s41380-024-02424-9 · 2024 · External reference

Fantastic voyage: the journey of intestinal microbiota-derived microvesicles through the body

10.1042/bst20180114 · 2018 · External reference

Role of microbiota-derived extracellular vesicles in gut-brain communication

10.3390/ijms22084235 · 2021 · External reference

Microbiota-derived extracellular vesicles: current knowledge, gaps, and challenges in precision nutrition

10.3389/fimmu.2025.1514726 · 2025 · External reference

The emerging role of human gut bacteria extracellular vesicles in mental disorders and developing new pharmaceuticals

10.3390/cimb46050286 · 2024 · External reference

Emerging therapeutic role of gut microbial extracellular vesicles in neurological disorders

10.3389/fnins.2023.1241418 · 2023 · External reference

Microbiome analysis of circulating bacterial extracellular vesicles in obsessive-compulsive disorder

10.1111/pcn.13593 · 2023 · External reference

Unresolved reference

2013 · External reference

The Yale-Brown obsessive compulsive scale: I. Development, use, and reliability

10.1001/archpsyc.1989.01810110048007 · 1989 · External reference

Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale (SIGMA)

10.1192/bjp.bp.106.032532 · 2008 · External reference

Korean treatment algorithm for obsessive-compulsive disorder 2007 (I)

10.5124/jkma.2002.45.9.1129 · 2007 · External reference

Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials

10.1016/j.jad.2015.03.021 · 2015 · External reference

Application of a diazepam milligram equivalency algorithm to assess benzodiazepine dose intensity in Rhode Island in 2018

10.18553/jmcp.2022.28.1.58 · 2021 · External reference

Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder

10.1002/wps.20299 · 2016 · External reference

Key features and guidelines for the application of microbial alpha diversity metrics

10.1038/s41598-024-77864-y · 2025 · External reference

Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities

10.1128/aem.01996-06 · 2007 · External reference

Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions

10.1038/s41380-023-02287-6 · 2023 · External reference

The relationship between the gut microbiome-immune system-brain axis and major depressive disorder

10.3389/fneur.2021.721126 · 2021 · External reference

Role of the gut microbiome in three major psychiatric disorders

10.1017/s0033291722000897 · 2022 · External reference

Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges

10.1128/cmr.00058-16 · 2017 · External reference

Exploring the multifaceted genus Acinetobacter: the facts, the concerns and the oppoptunities the dualistic geuns Acinetobacter

10.4014/jmb.2411.11043 · 2025 · External reference

Acinetobacter species in the skin microbiota protect against allergic sensitization and inflammation

10.1016/j.jaci.2014.07.059 · 2014 · External reference

Host innate immune responses to Acinetobacter baumannii infection

10.3389/fcimb.2020.00486 · 2020 · External reference

Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models

10.1073/pnas.1711235114 · 2017 · External reference

The roles of extracellular vesicles in the immune system

10.1038/s41577-022-00763-8 · 2023 · External reference

The role of bacterial extracellular vesicles in the immune response to pathogens, and therapeutic opportunities

10.3390/ijms25116210 · 2024 · External reference

Bacteria extracellular vesicle as nanopharmaceuticals for versatile biomedical potential

10.1186/s40580-024-00434-5 · 2024 · External reference

Identifying the role of Acinetobacter calcoaceticus in driving intestinal inflammation

10.1093/ibd/izae020.134 · 2024 · External reference

Prevalence and correlates of low-grade systemic inflammation in adult psychiatric inpatients: An electronic health record-based study

10.1016/j.psyneuen.2018.02.031 · 2018 · External reference

Immune abnormalities across psychiatric disorders: clinical relevance

10.1192/apt.bp.114.012872 · 2015 · External reference

Low-grade inflammation predicts persistence of depressive symptoms

10.1007/s00213-015-3919-9 · 2016 · External reference

Obsessive-compulsive disorder: Autoimmunity and neuroinflammation

10.1007/s11920-019-1062-8 · 2019 · External reference

Immune system and obsessive-compulsive disorder

10.1016/j.psyneuen.2018.04.013 · 2018 · External reference

Host–microbe serotonin metabolism

10.1016/j.tem.2024.07.014 · 2025 · External reference

Revisiting the fight against Acinetobacter baumannii: Emerging non-antibiotic strategies

10.3390/antibiotics15030281 · 2026 · External reference

Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review

10.1080/19490976.2023.2287073 · 2023 · External reference

Baseline gut microbiota profiles affect treatment response in patients with depression

10.3389/fmicb.2024.1429116 · 2024 · External reference

The interplay between diet and the gut microbiome: implications for health and disease

10.1038/s41579-024-01068-4 · 2024 · External reference

The impact of diet and lifestyle on gut microbiota and human health

10.3390/nu7010017 · 2014 · External reference

Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals

10.1038/s41591-020-01183-8 · 2021 · External reference